welbournes

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (17/01/2025) announced the following list of price concessions for January 2025: Drug Pack size Price concession Acamprosate 333mg gastro-resistant tablets 168 £21.90 Bimatoprost 300micrograms/ml / Timolol 5mg/ml eye [...]

The post January 2025 Price Concessions 2nd Update appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (16/01/2025) announced the following initial list of price concessions for January 2025: Drug Pack size Price concession Alfuzosin 2.5mg tablets 60 £3.80 Calcipotriol 0.005% / Betamethasone dipropionate 0.05% [...]

The post January 2025 Price Concessions 1st Update appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Xylocaine® (lidocaine) 10mg spray MSN/2025/003 Tier 2 medium impact Date of issue: 14th January 2025 Xylocaine® (lidocaine) 10mg spray is out of stock until mid-February 2025. Lidocaine 5% / Phenylephrine 0.5% spray remains available and can support an increase in demand. [...]

The post Medicine Supply Notification: Xylocaine® (lidocaine) 10mg spray appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Apomorphine hydrochloride (APO-go® PFS) 50mg/10ml solution for infusion pre-filled syringes. MSN/2025/002 Tier 2 – medium impact Date of issue: 9th January 2025 APO-go® (apomorphine hydrochloride) PFS are being discontinued; supplies are anticipated to be exhausted from early April 2025. APO-go® POD [...]

The post Medicine Supply Notification: Apomorphine hydrochloride (APO-go® PFS) 50mg/10ml solution for infusion pre-filled syringes appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Rabeprazole sodium 10mg and 20mg gastro-resistant tablets (Bristol Laboratories Limited) Drug alert number: EL (25)A/01 Date issued: 09 January 2025 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Rabeprazole sodium 10mg and 20mg gastro-resistant tablets (Bristol Laboratories Limited) DMRC [...]

The post MHRA Class 4 Medicines Defect Notification: Rabeprazole sodium 10mg and 20mg gastro-resistant tablets (Bristol Laboratories Limited) appeared first on Community Pharmacy England.